Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$27,000.00
Differential Translation in Cellular Senescence: Identifying Vulnerabilities for Cancer Therapies
FY 2024-25
Summary
Treatments such as radiotherapy and chemotherapy target proliferative cells in a non-specific manner, which can result in cell cycle arrest. This mechanism prevents the propagation of damaged cells, but it can also promote adverse effects of cancer therapy. Some of these detrimental impacts are the amplification of treatment side effects, chronic inflammation, tumor metastasis and cancer recurrence. Therefore, eliminating these damaged cells could be an interesting approach to enhance the efficiency of treatments. In this context, we aim to examine molecular mechanisms responsible for protein synthesis in damaged cells to identify new vulnerabilities. The objective is to understand the mechanisms at play and modulate them to reduce side effects of cancer treatment while maintaining their efficacity and ameliorating patient quality of life of patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529713
Name
Hingray Émilie
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Prcname2
Special Cases - Awards Programs
Projecttitle
Differential Translation in Cellular Senescence: Identifying Vulnerabilities for Cancer Therapies
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cellular Senescence; Chemotherapy; Crispr; Mrna Translation; Protein Synthesis; Regulation Of Gene Expression; Rna
Abstract
Treatments such as radiotherapy and chemotherapy target proliferative cells in a non-specific manner, which can result in cell cycle arrest. This mechanism prevents the propagation of damaged cells, but it can also promote adverse effects of cancer therapy. Some of these detrimental impacts are the amplification of treatment side effects, chronic inflammation, tumor metastasis and cancer recurrence. Therefore, eliminating these damaged cells could be an interesting approach to enhance the efficiency of treatments. In this context, we aim to examine molecular mechanisms responsible for protein synthesis in damaged cells to identify new vulnerabilities. The objective is to understand the mechanisms at play and modulate them to reduce side effects of cancer treatment while maintaining their efficacity and ameliorating patient quality of life of patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hingray, Émilie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~